(Q33642590)

28 July 2017

1 reference

title

A review and commentary on a sample of 15 UK guidelines for the drug treatment of Alzheimer's disease (English)

1 reference

28 July 2017

0 references

R J Harvey

1

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 April 1999

1 reference

International Journal of Geriatric Psychiatry

28 July 2017

published in

1 reference

28 July 2017

volume

14

1 reference

28 July 2017

issue

4

1 reference

28 July 2017

page(s)

249-256

1 reference

North of England evidence based guidelines development project: methods of guideline development

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28199904%2914%3A4%3C249%3A%3AAID-GPS920%3E3.0.CO%3B2-T

Guidelines for clinical guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28199904%2914%3A4%3C249%3A%3AAID-GPS920%3E3.0.CO%3B2-T

Drug treatments for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28199904%2914%3A4%3C249%3A%3AAID-GPS920%3E3.0.CO%3B2-T

Guidelines on drug treatments for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28199904%2914%3A4%3C249%3A%3AAID-GPS920%3E3.0.CO%3B2-T

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28199904%2914%3A4%3C249%3A%3AAID-GPS920%3E3.0.CO%3B2-T

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28199904%2914%3A4%3C249%3A%3AAID-GPS920%3E3.0.CO%3B2-T

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28199904%2914%3A4%3C249%3A%3AAID-GPS920%3E3.0.CO%3B2-T

Tacrine for Alzheimer's disease: why is it not available on prescription to UK sufferers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28199904%2914%3A4%3C249%3A%3AAID-GPS920%3E3.0.CO%3B2-T

10.1002/(SICI)1099-1166(199904)14:4<249::AID-GPS920>3.0.CO;2-T

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference